The Cancer Biomarkers Research Group promotes research to identify, develop, and validate biological markers for early cancer detection and cancer risk assessment. Activities include development and validation of promising cancer biomarkers, collaborative databases and informatics systems, and new technologies or the refinement of existing technologies.
Read more About the Cancer Biomarkers Research Group.
Alliance of Glycobiologists for Cancer Research
Tumor Glycomics Laboratories work to reveal cancer-related dynamics of complex carbohydrates.
Early Detection Research Network (EDRN)
Labs and centers bring together comprehensive infrastructure and resources critical to discovery, development and validation of biomarkers for cancer risk and early detection.
Improving the Search for Biomarkers of Early Cancer Air Date: April 26, 2016
In the News: 34th Steering Committee Meeting of the EDRN
The 34th Steering Committee Meeting of the NCI Early Detection Research Network (EDRN) is joined by the investigators engaged in biomarker research and supported by Japan Agency for Medical Research and Development (AMED). This meeting takes place March 18-20, 2019.
Consortium for Imaging and Biomarkers (CIB) 4th Annual Principal Investigators Meeting
The Cancer Biomarkers Research Group (CBRG) will be hosting the Consortium for Imaging and Biomarkers (CIB) 4th Annual Principal Investigators Meeting on Monday, July 1, 2019, from 8:00 am to 5:00 pm, in conference room TE-110.